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Adherence to Guidelines for Youths With Diabetes
Mellitus
WHAT’S KNOWN ON THIS SUBJECT: Although children and
youths with diabetes mellitus are at increased risk for long-term
complications associated with disease duration, evidence
suggests that the quality of care for children and youths with
diabetes is less than ideal.
WHAT THIS STUDY ADDS: The findings of this study add evidence
supporting the need to assist youths with chronic health
conditions as they transition to adulthood and adult health care.
abstract
OBJECTIVE: To describe demographic and clinical characteristics as-
sociated with self-reported receipt of tests and measurements recom-
mended by the American Diabetes Association (ADA) for children and
youths with diabetes.
METHODS: The study included 1514 SEARCH for Diabetes in Youth study
participants who completed a survey about diabetes care received.
Quality-of-care measures were based on ADA guidelines for eye exam-
inations and glycohemoglobin (hemoglobin A1c [HbA1c]), lipid level,
microalbuminuria, and blood pressure measurements, and a compos-
ite variable of these 5 indicators was created. Multivariate logistic
regression models were used to assess the association of selected
demographic and clinical characteristics with the reported receipt of
all recommended tests and measurements according to age and dia-
betes type subgroups.
RESULTS: Overall, 95% of the participants reported having their blood
pressure checked at all or most visits, 88% had lipid levels measured,
83% had kidney function tested, 68% underwent HbA1c testing, and
66% underwent an eye examination, in accordance with ADA recom-
mendations. Participants aged 18 years or older, particularly those
with type 2 diabetes, tended to have fewer tests of all kinds performed.
Age and family income emerged as important correlates of overall
quality of care in multivariate models; older age and lower income
were associated with not meeting guidelines.
CONCLUSIONS: Although there was relatively good adherence to ADA-
recommended guidelines for most indicators, efforts are needed to
improve rates of HbA1c testing and eye examinations, particularly
among older youths. Pediatrics 2011;128:531–538
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Although children and youths with dia-
betesmellitus are at increased risk for
long-term complications associated
with disease duration,1,2 evidence sug-
gests that the quality of care for chil-
dren and youths with diabetes is less
than ideal. Low rates of glycohemoglo-
bin (hemoglobin A1c [HbA1c]) testing
and ophthalmologic assessments have
been reported, as well as inadequate
glycemic control and treatment of dys-
lipidemia.3–6 The assessment of quality
and outcomes of health care for chil-
dren has lagged behind that of adults
in the United States for a variety of rea-
sons, including the lack of a strong
“business case” for quality assess-
ment of children’s health care, com-
peting demands for funds, fewer
trained investigators, and fewer mea-
sures designed specifically to study
quality of care for children.7–10 Meth-
odologic issues also pose challenges
for the assessment of children’s qual-
ity of diabetes care, including age-
specific requirements for optimal dia-
betes treatment10,11 and different
measures of care quality for type 1 and
type 2 diabetes, reflecting the appar-
ent etiologic and physiologic differ-
ences between diabetes types.11 Fi-
nally, although diabetes is among the
most common chronic illness among
children and youths, the number of
youths with diabetes in any given geo-
graphic area or health care facility is
fairly small.
The SEARCH for Diabetes in Youth
study, a multicenter, population-based
study of children and youths with dia-
betes, provides a unique opportunity
tomeasure the quality of care received
by a large diverse sample of young
people with diabetes throughout the
United States. We evaluated the self-
reported quality of care received by
youths in this study by using the Amer-
ican Diabetes Association (ADA) guide-
lines for diabetes care,11 and we
assessed the association of sociode-
mographic and clinical factors with re-
ceiving recommended processes of
care for diabetes.
METHODS
SEARCH for Diabetes in Youth
Study Procedures
The SEARCH for Diabetes in Youth study
began population-based ascertain-
ment of youths with clinically diag-
nosed diabetes who were younger
than 20 years in 2001 (prevalence) and
youths with newly diagnosed diabetes
(incidence) beginning in 2002 and con-
tinuing through the present.12 Briefly,
cases of diabetes were identified in 4
geographically defined populations in
Ohio, Colorado, South Carolina, and
Washington, among Indian Health Ser-
vice beneficiaries from 4 American In-
dian populations, and among enrollees
in several health care plans in Califor-
nia and Hawaii. The institutional review
boards for all sites approved the study
protocol. Youths identified as having
diabetes were then invited to partici-
pate in an in-person visit, where in-
formed consent was obtained; physi-
cal measurements and fasting blood
samples were obtained from partici-
pants in metabolically stable condi-
tion, and questionnaires were admin-
istered.12 Participants whose diabetes
onset occurred in 2002–2005 (incident
cases) also were invited to follow-up
visits at 12, 24, and 60months after the
baseline visit.
Quality-of-Care Survey
The SEARCH for Diabetes in Youth study
survey on quality of care was designed
to solicit information about conformity
with ADA-recommended standards of
diabetes care, access to care, self-care
practices, and satisfaction with care.
Two versions of the survey were cre-
ated, 1 for participants aged 18 years
or older at the time of the survey, to be
completed by the participant, and 1 for
participants younger than 18 years, to
be completed by the participant’s par-
ent or guardian. All surveys were con-
ducted in English or Spanish.
Study Population
The quality-of-care survey was admin-
istered to 2 groups of SEARCH for Dia-
betes in Youth study participants. The
first group was composed of youths
whose diabetes was incident in 2002–
2005 and who had completed a
follow-up visit. Surveys were adminis-
tered to participants (or parents/
guardians for children younger than
18 years) at the 24-month follow-up
study visit (N 963). In this group, 912
participants (95%) completed the
quality-of-care survey. The second
group of participants consisted of
youths whose diabetes was prevalent
in 2001 andwho had completed a base-
line study visit (N  2534). Of those
participants, a sample was selected
for the quality-of-care survey in 2008,
including all youths from racial and
ethnic minority groups (N  770) and
a 10% random sample of non-Hispanic
white youths (N 174). Surveys for the
second group were completed by mail,
over the telephone, or via an Internet-
based survey application, between
September 2008 and March 2009. Of
the 944 participants selected to partic-
ipate in the prevalent diabetes survey,
613 (65%) completed the survey. This
sampling strategy yielded a total sam-
ple size of 1525 youths with type 1 or
type 2 diabetes and ensured broad
ranges of age, race/ethnicity, and du-
ration of diabetes, which all are poten-
tially related to the quality of care
received.
Quality-of-Care Measures
Dependent variables used in these
analyses were self-reported receipt of
5 specific, diabetes-related, processes
of care, namely, HbA1c and lipid test-
ing, blood pressure measurement, as-
sessment of microalbuminuria, and
dilated eye examination. These pro-
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cesses of care are based on ADA guide-
lines for diabetes care, with specific
requirements depending on age, dia-
betes type and duration, and medica-
tion regimen.11 For the purposes of this
study, the 5 processes were defined as
follows: (1) HbA1c testing: 3 times
per year if the patient was receiving
insulin or2 times per year if the pa-
tient was not receiving insulin; (2)
blood pressure measurement: at most
physician visits for all patients; (3) eye
examination: at least once in the past
year for patients with type 1 diabetes
who were 10 years of age and had
diabetes duration of5 years and for
all patients with type 2 diabetes; (4)
lipid level measurement: at least once
ever for patients 12 to 17 years of age
and at least once in the past year for
patients aged 18 years or older; (5) mi-
croalbuminuriameasurement: at least
once in the past year for patients with
type 2 diabetes and for patients with
type 1 diabetes who were 10 years of
age or older and had diabetes duration
of 5 years. Receipt of these tests/
measurements was assessed through
responses to questions in the SEARCH
for Diabetes in Youth study quality-of-
care survey (Appendix).
To measure the association of demo-
graphic and clinical factors with the
overall quality of care received, we
constructed a dichotomous quality-of-
care summary indicator. The value of
this summary indicator was calcu-
lated by first determining which of the
5 ADA-recommended tests each partic-
ipant should have received on the ba-
sis of his or her age, diabetes type, and
diabetes duration. The summary indi-
cator was assigned a value of 1 if the
participant had received all recom-
mended tests, and it was assigned a
value of 0 if the participant had not re-
ceived all of the recommended tests. In
this way, we were able to take into ac-
count differences in ADA test recom-
mendations among our diverse group
of children and youths and to assess
the overall processes of care received.
Covariates used in the analyses, in-
cluding gender, race/ethnicity, diabe-
tes type (determined on the basis of
health care providers’ reports), and
other demographic characteristics
were derived from information col-
lected at the time of enrollment into
the study. Age and diabetes duration
were calculated as of the date of sur-
vey completion. Information regarding
care provider specialty, type of health
insurance, and continuous insurance
coverage was collected as part of the
quality-of-care surveys.
Statistical Analyses
Of the 1525 participants who com-
pleted a quality-of-care survey, 10 did
not have type 1 or type 2 diabetes and
were excluded. One respondent’s age
could not be calculated and that re-
spondent was excluded, which left
1514 youths and young adults with di-
abetes available for this analysis. We
calculated the proportion of respon-
dents who had received each of the 5
individual tests, including only partici-
pants who met the criteria for each
test. Respondents who answered “do
not know/not sure” were excluded
from these analyses, because it could
not be determined whether they had
received the test.
Because of the high correlation of age
and diabetes type, these analyses
were stratified according to diabetes
type and age (ie, type 1 and 3–11 years
of age, type 1 and 12–17 years of age,
type 1 and 18 years of age or older,
type 2 and 12–17 years of age, or type 2
and 18 years of age or older). The 2
statistic was used to determine the sig-
nificance of differences between these
age/type groups and also among age
groups within diabetes type. P values of
.05 were considered significant.
The associations between quality of
care and selected demographic and
clinical characteristics were assessed
by using logistic regression models
with the quality-of-care summary vari-
able described above as the depen-
dent variable. Anticipating that demo-
graphic and clinical factorsmight have
different associations with the quality
of care received by participants in dif-
ferent age groups, we stratified these
multivariate analyses. Separate mod-
els were constructed for the entire
sample and for ages 3 to 11, 12 to 17,
and 18 years or older. All 4 models in-
cluded the variables of gender, race/
ethnicity, family composition (1- vs
2-parent household), family income,
type of health insurance, continuous
insurance during the previous 12
months, and diabetes care provider
specialty. The model for the entire
sample also was adjusted for age
group. Duration of diabetes was in-
cluded in preliminarymodels (data not
shown) but was excluded from the fi-
nal models because it was consistently
nonsignificant. All models included the
SEARCH for Diabetes in Youth study
center, to adjust for any potential dif-
ferences associated with study sites.
The analyses using the dichotomous
quality-of-care summary variable ex-
cluded cases that were missing data
for any test recommended on the ba-
sis of ADA criteria. Of the 1514 cases
in the first part of the analysis, 1212
(80%) had complete data for all rec-
ommended tests. An additional 125
cases were excluded from the multi-
variate models because of missing
covariate data, which resulted in
1087 cases (72% of our original sam-
ple) being included in these analy-
ses. All analyses were performed
with SAS 9.2 (SAS Institute, Inc, Cary,
NC).
RESULTS
Of the 1514 youths who completed the
quality-of-care survey, 85% had type 1
diabetes, 53% were female, and 84%
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were 12 years of age or older. Ages
ranged from 3 to 27 years, with a me-
dian of 15 years. Forty-eight percent of
the subjects were non-Hispanic white,
20% black, 21% Hispanic, and 11%
other (including Asian, Pacific Is-
lander, American Indian, and mixed
race/ethnicity, combined into 1 group
because of small sample sizes) (Table
1). The duration of diabetes at the time
of survey completion ranged from 23
to 288 months, with a median time
since diagnosis of 51 months. Overall,
5% of participants reported having no
insurance at the time of the survey and
11% reported gaps in insurance cover-
age during the preceding year, with
larger proportions among older
participants.
The proportions of participants who
reported receiving each of the 5 ADA-
recommended tests (among those
who met the criteria for receiving
them), according to age and diabetes
type, are presented in Table 2. Overall,
95% of participants reported undergo-
ing blood pressure checks at all or
most visits. Fewer participants re-
ported undergoing lipid levelmeasure-
ments (88%) and kidney function tests
(83%) with the frequency and time in-
tervals recommended by the ADA for
their respective diabetes type and age
group. Only 66% reported undergoing
an eye examination as recommended,
and 68% reported undergoing HbA1c
testing with the recommended fre-
quency. Rates for the incident and
prevalent cases included in the sample
were calculated separately, and no
substantive differences were found
(data not shown).
Participants aged 18 years or older
tended to have fewer tests of all kinds
performed regardless of their diabe-
tes type, but particularly with type 2
diabetes. Only 45% of participants
aged 18 years or older with type 2 dia-
betes reported having their HbA1c lev-
els measured with the recommended
frequency, compared with 70% of par-
ticipants 12 to 17 years of age (P 
.0009). Significant differences between
these 2 age groups also were found
with respect to lipid level and blood
pressure measurements and kidney
TABLE 1 Sociodemographic and Clinical Characteristics of the SEARCH for Diabetes in Youth Study Quality-of-Care Survey Sample, According to
Diabetes Type and Age
Characteristic Type 1 Diabetes Type 2 Diabetes Total
3–11 y 12–17 y 18 y 12–17 y 18 y
N 392 533 363 74 152 1514
Age, mean SD, y 8.9 2.2 15.2 1.7 21.2 2.3 15.8 1.5 21.9 2.5 15.7 5.2
Gender, n (%)
Female 201 (51) 270 (51) 182 (50) 50 (68) 97 (64) 800 (53)
Male 191 (49) 263 (49) 181 (40) 24 (32) 55 (36) 714 (47)
Race/ethnicity, n (%)
Non-Hispanic white 278 (71) 292 (55) 131 (36) 11 (15) 10 (7) 722 (48)
Black 39 (10) 89 (17) 76 (21) 35 (47) 66 (43) 305 (20)
Hispanic 46 (12) 110 (21) 114 (31) 20 (27) 29 (19) 319 (21)
Other 29 (7) 42 (8) 42 (12) 8 (11) 47 (31) 168 (11)
Annual family income, n (%)
Below $25 000 49 (13) 91 (17) 57 (17) 27 (36) 56 (38) 280 (19)
$25 000–$49 000 67 (17) 90 (17) 61 (18) 22 (30) 30 (20) 270 (18)
$50 000–$74 000 78 (20) 102 (19) 44 (13) 7 (9) 5 (3) 236 (16)
Above $75 000 175 (46) 213 (40) 68 (20) 4 (5) 10 (7) 470 (32)
Do not know/refused to answer 15 (4) 31 (6) 112 (33) 14 (19) 48 (32) 220 (15)
Family composition, n (%)
1-parent household 74 (19) 156 (31) 123 (37) 49 (71) 72 (56) 474 (33)
2-parent household 311 (81) 350 (69) 207 (63) 20 (29) 56 (44) 944 (67)
Type of insurance, n (%)
Private 296 (77) 401 (76) 214 (60) 29 (40) 59 (39) 999 (67)
Medicaid/Medicare 79 (20) 113 (21) 66 (19) 41 (56) 47 (31) 346 (23)
Other 7 (2) 6 (1) 44 (12) 2 (3) 16 (11) 75 (5)
None 4 (1) 8 (2) 32 (9) 1 (1) 28 (19) 73 (5)
Continuously insured in past 12 mo, n (%)
No 17 (4) 25 (5) 59 (16) 9 (12) 48 (32) 158 (11)
Yes 370 (96) 498 (95) 300 (84) 64 (88) 103 (68) 1335 (89)
Diabetes care provider, n (%)
Pediatric endocrinologist 270 (70) 385 (73) 87 (24) 60 (81) 23 (15) 825 (55)
Adult endocrinologist 3 (1) 26 (5) 160 (45) 0 (0) 25 (17) 214 (14)
Generalist 12 (3) 25 (5) 60 (17) 8 (11) 56 (37) 161 (11)
Nurse practitioner/physician assistant 94 (24) 85 (16) 34 (10) 5 (7) 16 (11) 234 (16)
Other 6 (2) 9 (2) 16 (4) 1 (1) 30 (20) 62 (4)
Duration of diabetes, mean SD, mo 45.5 19.5 68.9 43.3 121.5 61.4 42.6 11.9 86.6 34.8 75.9 51.1
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function testing. Among participants
with type 1 diabetes, significant differ-
ences between age groups were found
for HbA1c testing (55% for age 18 years
or older, compared with 73% for ages
12–17 years and 80% for age 11 years
or younger; P  .0001) and for lipid
level measurements (83% for age 18
years or older, compared with 96% for
ages 12–17 years; P .0001).
Three characteristics emerged as im-
portant correlates of quality of care
(P  .01) in the multivariate logistic
regression model including all 1087
participants with complete data,
namely, age group, family income, and
type of diabetes care provider (Table
3). The odds ratios for participants
aged 12 to 17 years and 18 years or
older receiving all of the recom-
mended tests were 0.60 (95% confi-
dence interval: 0.43–0.83) and 0.40
(95% confidence interval: 0.25–0.62),
respectively, compared with partici-
pants younger than 12 years of age.
Compared with individuals from fami-
lies with annual incomes of $25 000 or
less, individuals from families with an-
nual incomes of $75 000 had65% in-
creased odds of receiving all recom-
mended tests. Individuals who
received care from generalists and
other diabetes care providers were
less likely to receive all recommended
tests, compared with pediatric endo-
crinologists or nurse practitioners/
physician assistants. Family income
was significantly associated with the
TABLE 2 Proportion of Respondents Who Reported Receipt of Measurement, According to Age Category and Diabetes Type
No. Reported Receiving Test/No. Met Criteria for Test (%)
Type 1 Diabetes Type 2 Diabetes Total
3–11 ya 12–17 y 18 y 12–17 y 18 y
HbA1C level measuredb 302/377 (80)c 379/519 (73)c 191/346 (55)c 46/66 (70)c 58/130 (45)c 976/1438 (68)
Lipid levels measuredb NA 416/433 (96)c 262/315 (83)c 58/58 (100)c 86/125 (69)c 822/931 (88)
Blood pressure measuredb 360/380 (95) 508/526 (97) 339/353 (96) 69/72 (96)c 118/144 (82)c 1394/1475 (95)
Microalbuminuria measuredb 27/31 (87) 178/196 (91) 218/261 (84) 57/64 (89)c 86/132 (65)c 566/684 (83)
Eye examination performedb 20/34 (59) 155/209 (74) 187/278 (67) 46/69 (67) 74/141 (52) 482/731 (66)
Results include only data for subjects whomet the criteria for each test, and they exclude patients withmissing test data and thosewho responded “do not know.” NA indicates not applicable.
a The number of participants 10 to 11 years of age with a diabetes duration of5 years was 28.
b The 2 P value was.01 for differences among age/type groups for this measurement.
c Values were significantly different (P .05) between the age groups within diabetes type.
TABLE 3 Odds Ratios for Receiving All Recommended Tests, According to Demographic and Clinical
Characteristics









Gender, P — — — .0387
Male Reference Reference Reference Reference
Female 1.12 (0.85–1.46) 0.86 (0.52–1.43) 1.00 (0.65–1.53) 1.74 (1.03–2.95)
Age group, P .0001 — — —
12 y Reference — — —
12–17 y 0.60 (0.43–0.83) — — —
18 y 0.40 (0.25–0.62) — — —
Race/ethnicity, P — — .0281 —
White Reference Reference Reference Reference
Black 0.74 (0.49–1.13) 1.21 (0.45–3.26) 0.58 (0.30–1.12) 0.84 (0.38–1.88)
Hispanic 0.83 (0.55–1.27) 0.82 (0.31–2.15) 0.74 (0.39–1.43) 1.09 (0.50–2.37)
Other 0.65 (0.37–1.13) 0.74 (0.24–2.28) 0.24 (0.09–0.66) 2.20 (0.78–6.16)
Annual family income, P .0116 .0200 — —
Below $25 000 Reference Reference Reference Reference
$25 000–$49 000 0.83 (0.53–1.31) 0.78 (0.29–2.07) 0.68 (0.33–1.43) 1.22 (0.55–2.74)
$50 000–$74 000 1.41 (0.84–2.35) 2.61 (0.87–7.84) 1.01 (0.44–2.32) 1.65 (0.62–4.37)
Above $75 000 1.66 (1.01–2.71) 2.08 (0.72–6.00) 1.24 (0.54–2.87) 2.84 (1.15–7.00)
Do not know/refused to
answer
0.86 (0.51–1.45) 0.49 (0.11–2.16) 1.93 (0.63–5.92) 0.84 (0.40–1.81)
Family composition
2-parent household Reference Reference Reference Reference
1-parent household 1.06 (0.77–1.45) 0.85 (0.41–1.73) 1.06 (0.64–1.78) 1.29 (0.74–2.23)
Diabetes type
1 Reference — Reference Reference
2 0.84 (0.53–1.35) — .81 (0.39–1.70) .67 (0.33–1.37)
Diabetes care provider, P .0040 — — —
Pediatric endocrinologist Reference Reference Reference Reference
Adult endocrinologist 0.79 (0.49–1.26) — 1.06 (0.34–3.24) 0.59 (0.32–1.09)
Generalist 0.40 (0.24–0.68) — 0.36 (0.13–0.99) 0.37 (0.17–0.81)
Nurse practitioner/physician
assistant
1.01 (0.66–1.52) — 1.23 (0.63–2.38) 0.42 (0.16–1.12)
Other 0.32 (0.12–0.85) 0.83 (0.41–1.73) 1.93 (0.17–21.7) 0.12 (0.02–0.66)
Insurance type
Private Reference Reference Reference Reference
Medicaid/Medicare 1.13 (0.77–1.65) — — 1.02 (0.51–2.02)
Other 1.20 (0.59–2.44) 1.54 (0.71–3.33) 1.08 (0.58–2.01) 1.29 (0.53–3.10)
None 0.84 (0.33–2.15) — — 0.49 (0.13–1.80)
Continuously insured in past 12
mo
Yes Reference Reference Reference Reference
No 0.71 (0.39–1.30) 0.71 (0.21–2.39) 0.62 (0.23–1.67) 0.97 (0.39–2.39)
Analyses included only cases with no missing test or covariate data. Models included all variables shown plus the SEARCH
for Diabetes in Youth study site.
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quality-of-care summary variable (P
.02) for children between 3 and 11
years of age, race/ethnicity was signif-
icantly associated with quality of care
for youths between 12 and 17 years of
age (P .03), and gender and diabetes
care provider specialty were associated
with quality of care for participants aged
18yearsorolder (P .04). Typeofhealth
insurance and 1- versus 2-parent house-
hold did not account for significant dif-
ferences in receipt of care.
DISCUSSION
Our study confirms previous findings
that children and youths are vulnera-
ble to receiving suboptimal ambula-
tory care.8,13,14 Children and youths
with diabetes may face a greater risk
of complications than do thosewho de-
velop diabetes as adults, as a result of
the earlier age of onset leading to lon-
ger duration of disease.1,2,15 Although
the processes of care studied may not
result directly in better outcomes for
young people with diabetes, they are
important for early identification and
treatment of diabetes-related compli-
cations. The finding of suboptimal
HbA1c testing is particularly trouble-
some because poor glycemic control is
associated with complications.1 Rela-
tively low rates of eye examinations
among some participants also are
concerning. Other studies suggest that
cost barriers and possibly the inconve-
nience of visiting an eye care specialist
may contribute to suboptimal rates of
eye examinations.16,17
The results of this study indicate the
vulnerability of older adolescents and
young adults to receiving poorer qual-
ity of care. The transition to adulthood
for young people with diabetes re-
quires more responsibility for self-
care and medical care. At the same
time, there may be more perceived so-
cial pressure and desire to disregard
the self-management required for op-
timal management of diabetes.18 Simi-
larly, the transition from pediatric to
adult health care providers can result
in the breakdown of established, effec-
tive, doctor-patient relationships,
changes in the location of care, and
possibly changes in health care bene-
fits.3,19,20 Access problems, including
being uninsured and having gaps in
health insurance coverage, were more
common among this group. On the ba-
sis of this cross-sectional analysis, we
cannot say with certainty that quality of
care for diabetes decreases as youths
mature to young adulthood, although re-
sults suggest this. Quality of care may
improve in later years; however, lapses
in quality of care at any time during the
courseofdiabetesmaybedetrimental to
long-term outcomes.
Our findings highlight the significant
association of income with receiving
recommended tests, an association
that remained after we controlled for
other variables. Out-of-pocket medical
care costs affect the utilization of pre-
ventive services for diabetes in adult
populations and pose greater financial
barriers to care for economically dis-
advantaged patients.16 Lower rates of
eye examinations in particular have
been found among low-income adult
populations,21 and an eye examination
was themost-oftenmissed examination/
test in our study. The mechanisms
through which income, and socioeco-
nomic position in general, can affect dia-
betes care are complex22 and potentially
have an impact onmany aspects ofmed-
ical care, self-management, and ulti-
mately outcomes of care.
There are limitations of this study that
should be noted. First, the study relied
on self-reported receipt of recom-
mended diabetes tests and measure-
ments. There is some evidence of good
concordance between medical record
and survey data regarding ambulatory
care services.23 In addition, all ques-
tions about receipt of services allowed
respondents to reply “do not know/not
sure.” Very few respondents chose this
response option for HbA1c testing,
blood pressure measurement, and eye
examinations (proportions respond-
ing “do not know” or “not sure” ranged
from 2.0% to 4%), although there was
somewhat less certainty about lipid
level and kidney function testing (18%
and 13%, respectively). Evidence also
suggests that self-reports of eye exam-
inations and HbA1c testing actually
may overestimate the services per-
formed.24 Therefore, the true rates of
receipt of these 2 tests may be lower
than the results we found.
Although process measures of care
are important indicators of quality, re-
ceipt of these services depends on
many factors. Our study data do not
enable us to determine the degree to
which failure to receive recommended
care was attributable to patients, pro-
viders, health care systems, or other
barriers to care. Also, the dichoto-
mously coded, quality-of-care sum-
mary indicator reflects whether par-
ticipants reported receiving all of the
tests recommended by the ADA on the
basis of their age, diabetes type, and
diabetes duration. The indicator does
not take into account the number of
recommended tests that were missed.
Because 5 tests are recommended for
older participants and those with type 2
diabetes, compared with only 2 tests for
most youngerparticipantswith type 1di-
abetes, older participants had a greater
chance of missing a test and failing to
meet the criteria for having optimal
diabetes-related care. Nevertheless, as-
sessments of individual quality mea-
sures showed poorer results for youths
aged 18 years or older than for younger
participants, with few exceptions.
Strengths of this study include recruit-
ment from a population-based sample,
racial/ethnic and socioeconomic di-
versity, ages ranging from 3 to 27
years, participants with type 1 and
type 2 diabetes, and the use of well-
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established indicators of diabetes-
related health care quality. Study re-
sults also are based on a broad
spectrum of diabetes care delivery
models throughout the United States,
with diversity in provider specialties
and delivery settings.
CONCLUSIONS
The results of this study can provide
direction for intervention strategies to
improve the care and outcomes of chil-
dren and youths with diabetes. Our
findings add evidence supporting the
need to assist youths with chronic
health conditions as they transition
to adulthood and adult health care.
Our finding that income is associated
with reported receipt of recom-
mended diabetes-related services
highlights the potential impact of
cost barriers on other aspects of
care, which warrants further investi-




1. A test for hemoglobin A1c (“A one C”)
measures the average level of blood
sugar over the past 3 months. About
how many times in the past 12
months has a doctor or other health
care provider checked your hemoglo-
bin A1c (none, once, twice, 3 or more
times, or do not know/not sure)?
2. During the past 12months, how often
has your blood pressure been
checkedduring visits to your doctor’s
office (every visit, most visits, at least
once, never, or do not know/not
sure)?
3. When was the last time you had
your eyes examined by an eye spe-
cialist in which your pupils were di-
lated (drops in your eyes that make
eyes temporarily sensitive to bright
light) or had a diabetes eye exami-
nation (in the past year, 1 year
but2 years, 2–5 years,5 years,
never, or do not know/not sure)?
4. When was the last time your doctor
tookasampleof yourblood to test for
cholesterol or theamount of fat in the
blood (in the past year,1 year but
2years, 2–5years,5years, never,
or do not know/not sure)?
5. When was the last time you had a
urine test at the doctor’s office to
check kidney function (in the past
year, 1 year but 2 years, 2–5
years, 5 years, never, or do not
know/not sure)?
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